Cidara Therapeutics Announces Late-Breaking Presentation on CD388 at 10áµÊ° ESWI Influenza Conference 2025
Cidara Therapeutics Announces Late-Breaking Presentation on CD388 at 10ᵗʰ ESWI Influenza Conference 2025 GlobeNewswire October 23, 2025 SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak(R) platform to develop drug-Fc conjugate (DFC) therapeutics, today announced it gave a late-breaking presentation on its non-vaccine influenza […]